BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 17447528)

  • 1. [Therapeutic strategy for muscular dystrophies].
    Shin JH; Takeda S
    Brain Nerve; 2007 Apr; 59(4):415-24. PubMed ID: 17447528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for muscular dystrophy: current progress and future prospects.
    Trollet C; Athanasopoulos T; Popplewell L; Malerba A; Dickson G
    Expert Opin Biol Ther; 2009 Jul; 9(7):849-66. PubMed ID: 19527108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of gene therapy for muscle diseases.
    Thirion C; Lochmüller H
    Drug News Perspect; 2007; 20(6):357-63. PubMed ID: 17925889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AAV-directed muscular dystrophy gene therapy.
    Tang Y; Cummins J; Huard J; Wang B
    Expert Opin Biol Ther; 2010 Mar; 10(3):395-408. PubMed ID: 20132060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current understanding of dystrophin-related muscular dystrophy and therapeutic challenges ahead.
    Zhou GQ; Xie HQ; Zhang SZ; Yang ZM
    Chin Med J (Engl); 2006 Aug; 119(16):1381-91. PubMed ID: 16934185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dystrophin and muscular dystrophy: past, present, and future.
    O'Brien KF; Kunkel LM
    Mol Genet Metab; 2001; 74(1-2):75-88. PubMed ID: 11592805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic administration of naked DNA: gene transfer to skeletal muscle.
    Liu F; Liang KW; Huang L
    Mol Interv; 2001 Aug; 1(3):168-72. PubMed ID: 14993350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration.
    Bertoni C; Jarrahian S; Wheeler TM; Li Y; Olivares EC; Calos MP; Rando TA
    Proc Natl Acad Sci U S A; 2006 Jan; 103(2):419-24. PubMed ID: 16387861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular therapy of muscular dystrophy].
    Takeda S
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1267-9. PubMed ID: 11464475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy progress and prospects: Duchenne muscular dystrophy.
    Foster K; Foster H; Dickson JG
    Gene Ther; 2006 Dec; 13(24):1677-85. PubMed ID: 17066097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular approaches to therapy for Duchenne and limb-girdle muscular dystrophy.
    Stedman HH
    Curr Opin Mol Ther; 2001 Aug; 3(4):350-6. PubMed ID: 11525558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current state and prospects for gene therapy of Duchenne muscular dystrophy in the world and in Russia].
    Baranov VS; Baranov AN; Zelenin AV
    Genetika; 2001 Aug; 37(8):1046-54. PubMed ID: 11642103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological strategies for muscular dystrophy.
    Khurana TS; Davies KE
    Nat Rev Drug Discov; 2003 May; 2(5):379-90. PubMed ID: 12750741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Updates in muscular dystrophies].
    Erazo-Torricelli R
    Rev Neurol; 2004 Nov 1-15; 39(9):860-71. PubMed ID: 15543503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outlook for therapy in the muscular dystrophies.
    Tawil R
    Semin Neurol; 1999; 19(1):81-6. PubMed ID: 10711991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cellular therapy and gene therapy: perspectives in neuromuscular pathology].
    Fardeau M
    Pathol Biol (Paris); 1993 Oct; 41(8):681-5. PubMed ID: 8290312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The principles of gene therapy in Duchenne muscular dystrophy.
    Karpati G; Acsadi G
    Clin Invest Med; 1994 Oct; 17(5):499-509. PubMed ID: 7867254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adeno-associated virus for the treatment of muscle diseases: toward clinical trials.
    DiPrimio N; McPhee SW; Samulski RJ
    Curr Opin Mol Ther; 2010 Oct; 12(5):553-60. PubMed ID: 20886387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy.
    Aartsma-Rus A; Janson AA; van Ommen GJ; van Deutekom JC
    BMC Med Genet; 2007 Jul; 8():43. PubMed ID: 17612397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products.
    Yuasa K; Yoshimura M; Urasawa N; Ohshima S; Howell JM; Nakamura A; Hijikata T; Miyagoe-Suzuki Y; Takeda S
    Gene Ther; 2007 Sep; 14(17):1249-60. PubMed ID: 17581597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.